# Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias

> **NCT02921477** · PHASE1 · UNKNOWN · sponsor: **Neurological Associates of West Los Angeles** · enrollment: 150 (estimated)

## Conditions studied

- Mild Cognitive Impairment
- Dementia

## Interventions

- **DRUG:** bosutinib

## Key facts

- **NCT ID:** NCT02921477
- **Lead sponsor:** Neurological Associates of West Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02921477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02921477, "Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02921477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*